Home LiteratureArticle Details
PMID: 1280056 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.

Antimicrobial agents and chemotherapy ·Vol. 36 ·No. 10 ·1992-10-00 ·Pages 2280-5

Burns JL, Clark DK

Abstract

The most common mechanism of antibiotic resistance in multiply resistant Pseudomonas cepacia is decreased porin-mediated outer membrane permeability. In some gram-negative organisms this form of antibiotic resistance can be induced by growth in the presence of weak acids, such as salicylates, which suppress porin synthesis. To determine the effects of salicylates on outer membrane permeability of P. cepacia, a susceptible laboratory strain, 249-2, was grown in 10 mM sodium salicylate. Antibiotic susceptibility and uptake, as well as outer membrane protein patterns, were compared between strain 249-2 grown with and without salicylates. The MICs of chloramphenicol, trimethoprim, ciprofloxacin, and ceftazidime were compared between organisms grown in standard and salicylate-containing medium and are as follows: chloramphenicol, 12.5 versus 100 micrograms/ml; trimethoprim, 0.78 versus 3.125 micrograms/ml; ciprofloxacin, 0.4 versus 1.56 micrograms/ml; ceftazidime, 3.125 versus 3.125 micrograms/ml. The permeability of beta-lactam antibiotics was calculated from the rate of hydrolysis of the chromogenic cephalosporin, PADAC. There was no significant difference between strains grown in the presence and absence of salicylate. By using high-pressure liquid chromatography quantitation of loss from culture medium, the effect of 10 mM salicylate on the cellular permeability of chloramphenicol was measured in strain 249-2 by introduction of a plasmid which encodes production of chloramphenicol acetyltransferase. After 1 h of incubation, 18.5% +/- 1.54% versus 70.1% +/- 3.52%, and after 2 h, 4.20% +/- 1.65% versus 41.90% +/- 2.16% remained in supernatants from organisms grown in the absence and presence of 10 mM salicylate, respectively. Outer membrane protein pattern analysis demonstrated the absence of a protein of apparent molecular weight of 40,000 when strain 249-2 was grown in the presence of 10 mM salicylate. To determine whether this protein functioned as a porin, reconstituted membrane vesicles were constructed to assess antibiotic permeability. Vesicles constructed with this salicylate-suppressible outer membrane protein (OpcS) were permeable to chloramphenicol but not to penicillin G. These findings suggest that OpcS is a selective, antibiotic-permeable porin which can be suppressed by growth in the presence of salicylate. Further investigation will be required to determine the biochemical effects of salicylate on porin synthesis.

MeSH Terms
Anti-Bacterial Agents/metabolism,pharmacology Bacterial Outer Membrane Proteins/metabolism Burkholderia cepacia/drug effects,metabolism Drug Interactions Drug Resistance, Microbial Lactams Microbial Sensitivity Tests Salicylates/pharmacology
Chemicals
Anti-Bacterial Agents Bacterial Outer Membrane Proteins Lactams Salicylates
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Burns J L
Division of Infectious Disease, Children's Hospital and Medical Center, Seattle, Washington.
Clark D K
References (41)
41 references, click to expand
  1. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.
    Johns Hopkins Med J. 1980 Nov;147(5):188-9 PMID: 7441939
  2. Pseudomonas cepacia: implications and control of epidemic nosocomial colonization.
    Rev Infect Dis. 1981 Jul-Aug;3(4):708-15 PMID: 7339783
  3. Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source.
    J Bacteriol. 1979 Dec;140(3):1126-8 PMID: 533766
  4. Potentiation of susceptibility to aminoglycosides by salicylate in Escherichia coli.
    Antimicrob Agents Chemother. 1990 May;34(5):786-91 PMID: 2193619
  5. Transmembrane signal transduction and osmoregulation in Escherichia coli: II. The osmotic sensor, EnvZ, located in the isolated cytoplasmic membrane displays its phosphorylation and dephosphorylation abilities as to the activator protein, OmpR.
    J Biochem. 1990 Sep;108(3):488-93 PMID: 2277042
  6. Function of micF as an antisense RNA in osmoregulatory expression of the ompF gene in Escherichia coli.
    J Bacteriol. 1987 Jul;169(7):3007-12 PMID: 2439487
  7. Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability.
    Antimicrob Agents Chemother. 1989 Feb;33(2):136-41 PMID: 2719457
  8. Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates.
    Antimicrob Agents Chemother. 1988 Nov;32(11):1636-9 PMID: 2855296
  9. Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia.
    Antimicrob Agents Chemother. 1987 Jan;31(1):121-3 PMID: 3032087
  10. Differences in drug susceptibility between isolates of Pseudomonas cepacia recovered from patients with cystic fibrosis and other sources and its relationship to beta-lactamase focusing pattern.
    Pediatr Pulmonol. 1986 Nov-Dec;2(6):368-72 PMID: 3492701
  11. Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.
    Antimicrob Agents Chemother. 1977 Sep;12(3):368-72 PMID: 334063
  12. Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia.
    Biochem Biophys Res Commun. 1978 Jul 28;83(2):550-7 PMID: 358984
  13. Signal transduction and gene regulation through the phosphorylation of two regulatory components: the molecular basis for the osmotic regulation of the porin genes.
    Mol Microbiol. 1990 Jul;4(7):1077-82 PMID: 1700256
  14. Regulation of ompF porin expression by salicylate in Escherichia coli.
    J Bacteriol. 1991 Sep;173(18):5631-8 PMID: 1715858
  15. Transmembrane signal transduction and osmoregulation in Escherichia coli: I. Analysis by site-directed mutagenesis of the amino acid residues involved in phosphotransfer between the two regulatory components, EnvZ and OmpR.
    J Biochem. 1990 Sep;108(3):483-7 PMID: 2277041
  16. Role of porins in outer membrane permeability.
    J Bacteriol. 1987 Mar;169(3):929-33 PMID: 2434461
  17. Decreased permeation of cephalosporins through the outer membrane of Escherichia coli grown in salicylates.
    Antimicrob Agents Chemother. 1989 Apr;33(4):412-7 PMID: 2658790
  18. Outer membrane barrier as a mechanism of antimicrobial resistance.
    Antimicrob Agents Chemother. 1989 Nov;33(11):1831-6 PMID: 2692513
  19. Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia.
    Antimicrob Agents Chemother. 1989 Aug;33(8):1247-51 PMID: 2802552
  20. Mutations that define the promoter of ompF, a gene specifying a major outer membrane porin protein.
    J Bacteriol. 1985 Jun;162(3):1054-60 PMID: 2987180
  21. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.
    Antimicrob Agents Chemother. 1986 Dec;30(6):923-6 PMID: 3028253
  22. Isolation and characterization of a penicillinase from Pseudomonas cepacia 249.
    Antimicrob Agents Chemother. 1988 Jun;32(6):838-43 PMID: 3046483
  23. Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.
    Pediatr Res. 1986 Nov;20(11):1174-7 PMID: 3540826
  24. A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae.
    Antimicrob Agents Chemother. 1985 Jan;27(1):46-54 PMID: 3872625
  25. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.
    Pediatr Infect Dis. 1985 Mar-Apr;4(2):172-7 PMID: 3885181
  26. Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
    N Engl J Med. 1970 Jan 1;282(1):33-5 PMID: 4901384
  27. Colonization and infection with Pseudomonas cepacia.
    J Infect Dis. 1972 Jun;125(6):613-8 PMID: 5037014
  28. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  29. Regulation of outer membrane porin protein synthesis in Escherichia coli K-12: ompF regulates the expression of ompC.
    J Bacteriol. 1983 May;154(2):669-75 PMID: 6302079
  30. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.
    J Antimicrob Chemother. 1983 Jul;12 Suppl A:331-6 PMID: 6352638
  31. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.
    J Bacteriol. 1983 Aug;155(2):831-8 PMID: 6409884
  32. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
    J Pediatr. 1984 Feb;104(2):206-10 PMID: 6420530
  33. Purification and properties of a new beta-lactamase from Pseudomonas cepacia.
    Antimicrob Agents Chemother. 1980 Mar;17(3):355-8 PMID: 6968539
  34. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.
    J Clin Microbiol. 1987 Sep;25(9):1730-4 PMID: 3654943
  35. Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12.
    Proc Natl Acad Sci U S A. 1985 Dec;82(24):8771-4 PMID: 3909154
  36. Characterization of chloramphenicol acetyltransferase from chloramphenicol-resistant Staphylococcus aureus.
    J Bacteriol. 1968 Jan;95(1):28-36 PMID: 4965980
  37. Porin channels in Escherichia coli: studies with beta-lactams in intact cells.
    J Bacteriol. 1983 Jan;153(1):232-40 PMID: 6294048
  38. Promoter exchange between ompF and ompC, genes for osmoregulated major outer membrane proteins of Escherichia coli K-12.
    J Bacteriol. 1984 Jun;158(3):1041-7 PMID: 6327622
  39. Mutation causing reverse osmoregulation of synthesis of OmpF, a major outer membrane protein of Escherichia coli.
    J Bacteriol. 1984 Aug;159(2):688-92 PMID: 6378888
  40. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane.
    Antimicrob Agents Chemother. 1984 Jul;26(1):48-52 PMID: 6433788
  41. Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier.
    J Bacteriol. 1978 Oct;136(1):381-90 PMID: 101518
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1992-10-00
Pages
2280-5
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC245490
Subset
IM
Grants
NIAID NIH HHS · AI23975 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]